BUY MBP ZIDOVUDINE 300 MG/LAMIVUDINE 150 MG LAZID 60Tab BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Zidovudine 300 mg and lamivudine 150 mg is a fixed-dose combination medicine used in the treatment of HIV infection. It is commonly used as part of combination antiretroviral therapy and helps reduce the amount of virus in the body, protect the immune system, and slow the progression of HIV to AIDS. This medicine does not cure HIV, but when taken correctly, it allows people living with HIV to live long, healthy lives.

This combination works by blocking an enzyme called reverse transcriptase, which HIV needs to make copies of itself. Zidovudine and lamivudine both belong to a group of medicines called nucleoside reverse transcriptase inhibitors. By stopping viral replication, they reduce the amount of virus in the blood and help increase CD4 immune cells, which protect the body from infections.

Zidovudine and lamivudine are usually taken twice daily, about 12 hours apart, with or without food. It is very important to take the medicine at the same time every day. Missing doses can allow the virus to multiply and become resistant, making treatment less effective.

During the first few weeks of treatment, some people may experience side effects such as nausea, vomiting, headache, tiredness, dizziness, or mild stomach discomfort. These usually improve as the body adjusts to the medicine. Taking the medication with food may help reduce stomach upset.

Zidovudine can affect the bone marrow, leading to reduced red or white blood cell counts. This may cause tiredness, shortness of breath, pale skin, or increased risk of infections. Because of this, regular blood tests are important to monitor blood counts, especially during the early months of treatment.

Lamivudine is generally well tolerated, but stopping it suddenly in people who also have hepatitis B can cause a serious flare-up of liver disease. For this reason, treatment should never be stopped without medical advice.

This combination can also affect the liver, especially in people with hepatitis B or C. Symptoms such as yellowing of the eyes or skin, dark urine, abdominal pain, nausea, or unusual fatigue should be reported immediately. Liver function tests are routinely monitored during treatment.

Zidovudine may cause muscle weakness or muscle pain with long-term use, and in rare cases, it may lead to a condition called lactic acidosis, which is a serious buildup of acid in the blood. Symptoms include deep or rapid breathing, severe tiredness, nausea, or abdominal pain, and require urgent medical attention.

This medicine can be used during pregnancy under medical supervision and is often part of treatment to prevent mother-to-child transmission of HIV. Breastfeeding is not recommended for people living with HIV because of the risk of transmission.

Zidovudine and lamivudine can interact with other medications, including some antiviral drugs, chemotherapy agents, and medicines that affect blood cells. Always inform your healthcare provider about all medications and supplements you are taking.

When taken consistently and correctly, this combination significantly reduces viral load, improves immune function, lowers the risk of HIV-related infections, and supports long-term health. Regular follow-up, blood tests, and adherence to treatment are essential for the best outcomes.